11. ROB table: sarilumab vs standard care(SC). All‐cause mortality (≥ D60).
| Study | 1.Randomisation | 2.Deviations from intervention | 3.Missing outcome data | 4.Measurement of the outcome | 5.Selection of the reported results | Overall risk of bias |
| Lescure 2021 | Low | Low | Low | Low | Some concerns 1 | Some concerns |
1 Comment: the study registry was available. Mortality outcome was not pre‐specified for day 60 in the registry. No information whether the result was selected from multiple outcome measurements or analyses of the data.